Table 1 Patient characteristics.
AI (n = 70) | GD (n = 73) | |
|---|---|---|
Age in years, median (IQR; range) | 55.5 (46–62; 25–70) | 54.0 (43–61; 24–70) |
Sex (male/female) | 39 (56%)/31 (44%) | 42 (58%)/31 (42%) |
ECOG performance status (0/1) | 60 (86%)/10 (14%) | 62 (85%)/11 (15%) |
Histological subtype | ||
Liposarcoma | 21 (30%) | 16 (22%) |
Myxoid liposarcoma | 11 (16%) | 7 (10%) |
Dedifferentiated liposarcoma | 7 (10%) | 7 (10%) |
Pleomorphic liposarcoma | 3 (4%) | 2 (3%) |
Undifferentiated pleomorphic sarcoma | 13 (19%) | 22 (30%) |
Synovial sarcoma | 11 (16%) | 9 (12%) |
Myxofibrosarcoma | 9 (13%) | 9 (12%) |
Leiomyosarcoma | 3 (4%) | 7 (10%) |
Others | 13 (19%) | 10 (14%) |
Site (extremity/trunk) | 62 (89%)/8 (11%) | 61 (84%)/12 (16%) |
Tumour status (primary/recurrent) | 69 (99%)/1 (1%) | 70 (96%)/3 (4%) |
Lymph node (N0/N1) | 68 (97%)/2 (3%) | 71 (97%)/2 (3%) |
Tumour size in cm, median (IQR; range) | 9.0 (6.6–12.6; 5.0–26.5) | 10.2 (7.5–12.1; 3.7–32.0) |
Histological grade (2/3) | 48 (69%)/22 (31%) | 37 (51%)/36 (49%) |
AJCC Stage (IIB/III/IV) | 44 (63%)/24 (34%)/2 (3%) | 35 (48%)/36 (49%)/2 (3%) |
